pubmed.ncbi.nlm.nih.gov

Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY) - PubMed

. 2019 May;42(5):789-796.

doi: 10.2337/dc18-2315. Epub 2019 Feb 22.

Affiliations

Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY)

Nicolai A Lund-Blix et al. Diabetes Care. 2019 May.

Abstract

Objective: To study the association of gluten intake with development of islet autoimmunity and progression to type 1 diabetes.

Research design and methods: The Diabetes Autoimmunity Study in the Young (DAISY) follows children with an increased risk of type 1 diabetes. Blood samples were collected at 9, 15, and 24 months of age, and annually thereafter. Islet autoimmunity was defined by the appearance of at least one autoantibody against insulin, IA2, GAD, or ZnT8 (zinc transporter 8) in at least two consecutive blood samples. Using food frequency questionnaires, we estimated the gluten intake (in grams per day) annually from 1 year of age. Cox regression modeling early gluten intake, and joint modeling of the cumulative gluten intake during follow-up, were used to estimate hazard ratios adjusted for confounders (aHR).

Results: By August 2017, 1,916 subjects were included (median age at end of follow-up 13.5 years), islet autoimmunity had developed in 178 participants, and 56 of these progressed to type 1 diabetes. We found no association between islet autoimmunity and gluten intake at 1-2 years of age or during follow-up (aHR per 4 g/day increase in gluten intake 1.00, 95% CI 0.85-1.17 and 1.01, 0.99-1.02, respectively). We found similar null results for progression from islet autoimmunity to type 1 diabetes. Introduction of gluten at <4 months of age was associated with an increased risk of progressing from islet autoimmunity to type 1 diabetes compared with introduction at 4-5.9 months (aHR 8.69, 95% CI 1.69-44.8).

Conclusions: Our findings indicate no strong rationale to reduce the amount of gluten in high-risk children to prevent development of type 1 diabetes.

© 2019 by the American Diabetes Association.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Flow chart of the DAISY cohort. IA, islet autoimmunity; T1D, type 1 diabetes. *Cohort for joint modeling analyses was used in analyses of cumulative amount of gluten intake during follow-up and the risk of IA and progression from IA to T1D. †Cohort for Cox model analyses was used in analyses of age at the introduction of gluten, the amount of gluten intake at age 1–2 years, and the risk of IA and progression from IA to T1D.

Figure 2
Figure 2

Probability of islet autoimmunity (A) and progression to type 1 diabetes (B) according to tertiles for the amount of gluten intake at age 1–2 years. 1 = lowest third; 2 = middle third; 3 = highest third. When comparing subjects in the lowest third of gluten intake at age 1–2 years to those in the middle and highest third, we found no association with the risk of the development of islet autoimmunity or progression from islet autoimmunity to type 1 diabetes (all P values >0.47).

Similar articles

Cited by

References

    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014;383:69–82 - PMC - PubMed
    1. Patterson CC, Gyürüs E, Rosenbauer J, et al. . Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012;55:2142–2147 - PubMed
    1. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013;310:427–428 - PubMed
    1. Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G; Norwegian Childhood Diabetes Study Group . Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014;57:57–62 - PubMed
    1. Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes. Med Hypotheses 2007;68:607–619 - PubMed

Publication types

MeSH terms

Substances